CDK4/6 Inhibition as a therapeutic strategy in breast cancer: palbociclib, ribociclib, and abemaciclib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDK4/6 Inhibition as a therapeutic strategy in breast cancer: palbociclib, ribociclib, and abemaciclib

Published:2017-12 Issue:6 Volume:44 Page:395-403
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Laderian Bahar,Fojo Tito

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference21 articles.

1. US Breast Statistics. Breastcancer.org. Available at: http://www.breastcancer.org/symptoms/understand_bc/statistics.

2. Cancer Facts & Figures 2018,2018

3. World Health Organization. Breast cancer: prevention and control. Available at: http://www.who.int/cancer/en/.

4. Coombs S, Abraham J. This issue of Seminars in Oncology.

5. CDK4/6 inhibition triggers anti-tumor immunity;Goel;Nature,2017

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on nanocarriers as a targeted delivery system for the treatment of breast cancer;Intelligent Pharmacy;2024-06

2. DNA hypomethylation activates Cdk4/6 and Atr to induce DNA replication and cell cycle arrest to constrain liver outgrowth in zebrafish;Nucleic Acids Research;2024-02-07

3. Insights into the selectivity of a brain-penetrant CDK4/6 vs CDK1/2 inhibitor for glioblastoma used in multiple replica molecular dynamics simulations;Journal of Biomolecular Structure and Dynamics;2023-12-19

4. CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety;Seminars in Oncology;2023-12

5. Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials;Breast Cancer Research and Treatment;2023-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3